Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

IMRX stock hub

Immuneering Corporation has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

IMRXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

337.7M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

IMRX

In the news

Latest news · IMRX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-43.1

P25 -105.6P50 -46.5P75 -3.1

ROIC-27.7

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All IMRX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

181

Groups with data

Currency

USD

Showing 181 of 181 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001790340
Company name	Immuneering Corporation
Country	United States
Country code	US
Cusip	45254E107
Employees	53
Employees Change	-13%
Employees Change Percent	-19.7
Enterprise value	$124.5M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-07-30
Isin	US45254E1073
Last refreshed	2026-05-10
Market cap	$337.7M
Market cap category	Small-Cap
Price	$5.22
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	IMRX
Website	https://immuneering.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-16.59%
FCF yield	-13.47%
P/B ratio	1.54x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-56M
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Profit Per Employee	$-1.1M
ROA	-26.07
Roa5y	-30.62
ROCE	-26.76
ROE	-43.12
Roe5y	-52.4
ROIC	-27.71

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	375.05%
Cagr3y	-13.19%
EPS Growth Quarters	4
EPS Growth Years	1
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$232M
Cash	$172.8M
Current Assets	$176.2M
Current Liabilities	$10.1M
Debt	$3.8M
Debt Equity	$0.02
Equity	$218.5M
Liabilities	$13.5M
Long Term Assets	$55.7M
Long Term Liabilities	$3.4M
Net Cash	$213.2M
Net Cash By Market Cap	$63.13
Net Cash Growth	566.6%
Net Debt Equity	$-0.98
Tangible Book Value	$211.5M
Tangible Book Value Per Share	$3.27
WACC	6.16

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	17.5
Net Working Capital	$-6.3M
Quick ratio	17.16
Working Capital	$166.2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-46.8%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	374.55%
200-day SMA	5.7
3Y total return	-34.59%
50-day SMA	5.33
50-day SMA vs 200-day SMA	50under200
All Time High	33.99
All Time High Change	-84.64%
All Time High Date	2021-08-06
All Time Low	1
All Time Low Change	422%
All Time Low Date	2024-08-16
ATR	0.32
Beta	0.36
Beta1y	1.72
Beta2y	1.78
Ch YTD	-20.67
High	5.26
High52	10.08
High52 Date	2025-09-22
High52ch	-48.21%
Low	5.11
Low52	1.1
Low52 Date	2025-05-12
Low52ch	374.55%
Ma50ch	-2.12%
Premarket Change Percent	-0.19
Premarket Price	$5.21
Premarket Volume	2,423
Price vs 200-day SMA	-8.36%
RSI	44.59
RSI Monthly	51.89
RSI Weekly	48.8
Sharpe ratio	1.84x
Sortino ratio	3.26
Tr YTD	-20.67
Tr1m	-0.19%
Tr1w	-2.79%
Tr3m	5.88%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Count Top	4
Analyst Price Target Top	$17.75
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.26
Operating Income	$-59.4M
Price target	$17.2
Price Target Change	$230
Price Target Change Top	$240

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	49,443,254%
Float Percent	76.42%
Shares Insiders	13.76%
Shares Institutions	41.11%
Shares Out	64,697,227
Shares Qo Q	62.82%
Shares Yo Y	46.8%
Short Float	19.43%
Short Ratio	9.06
Short Shares	14.85

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-51.8M
Average Volume	801,368.85x
Bv Per Share	3.38
CAPEX	$-142,226
Ch1m	-0.19
Ch1w	-2.79
Ch1y	374.5
Ch3m	5.88
Ch3y	-34.59
Ch6m	-24.24
Change	0%
Change From Open	0
Close	5.22
Days Gap	0
Depreciation Amortization	353,784
Dollar Volume	2,594,893.3
Earnings Date	2026-05-22
Earnings Time	amc
EBIT	$-59.4M
EBITDA	$-59M
EPS	$-1.27
F Score	2
FCF	$-45.5M
FCF EV Yield	-36.53x
FCF Per Share	$-0.7
Financing CF	226,583,147
Fiscal Year End	December
Founded	2,008
Goodwill	6,690,431
Investing CF	-88,738,247
Ipr	-65.2
Iprfo	-73.23
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-06
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-06
Ma150	5.73
Ma150ch	-8.87%
Ma20	5.52
Ma20ch	-5.38%
Net CF	92,500,305
Next Earnings Date	2026-05-22
Open	5.22
Optionable	Yes
Position In Range	73.33
Post Close	5.22
Postmarket Change Percent	-0.96
Postmarket Price	$5.17
Ppne	4,260,730
Pre Close	5.22
Price Date	2026-05-08
Ptbv Ratio	1.6
Relative Volume	0.62x
Share Based Comp	6,311,135
Tr6m	-24.24%
Us State	Massachusetts
Volume	497,106

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does IMRX pay a dividend?

Capital-return profile for this ticker.

Performance

IMRX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns IMRX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+41.1%

Float: +76.4% of shares outstanding

Insider ownership

+13.8%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

IMRX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.6

Neutral momentum band

Price vs 200-day MA

-8.4%

50/200-day relationship not available

Beta (5Y)

0.36

Less volatile than the market

Sharpe ratio

1.84

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About IMRX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current IMRX stock rating?

Immuneering Corporation is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full IMRX analysis?

The full report lives at /stocks/IMRX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for IMRX?

The latest report frames IMRX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the IMRX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.